IL90028A - Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof - Google Patents

Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof

Info

Publication number
IL90028A
IL90028A IL90028A IL9002889A IL90028A IL 90028 A IL90028 A IL 90028A IL 90028 A IL90028 A IL 90028A IL 9002889 A IL9002889 A IL 9002889A IL 90028 A IL90028 A IL 90028A
Authority
IL
Israel
Prior art keywords
kits
preparation
fatty acids
same
contrast medium
Prior art date
Application number
IL90028A
Other languages
English (en)
Other versions
IL90028A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL90028A0 publication Critical patent/IL90028A0/xx
Publication of IL90028A publication Critical patent/IL90028A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Acoustics & Sound (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Gyroscopes (AREA)
  • Air Conditioning Control Device (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL90028A 1988-10-07 1989-04-19 Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof IL90028A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834705A DE3834705A1 (de) 1988-10-07 1988-10-07 Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln

Publications (2)

Publication Number Publication Date
IL90028A0 IL90028A0 (en) 1989-12-15
IL90028A true IL90028A (en) 1993-01-31

Family

ID=6364930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90028A IL90028A (en) 1988-10-07 1989-04-19 Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof

Country Status (19)

Country Link
EP (1) EP0365467B1 (fi)
JP (1) JPH0737394B2 (fi)
KR (1) KR970001433B1 (fi)
CN (1) CN1027575C (fi)
AT (1) ATE93145T1 (fi)
AU (1) AU627456B2 (fi)
CA (1) CA1338507C (fi)
DE (2) DE3834705A1 (fi)
DK (1) DK99789A (fi)
ES (1) ES2059814T3 (fi)
FI (1) FI100170B (fi)
IE (1) IE65243B1 (fi)
IL (1) IL90028A (fi)
LU (1) LU90004I2 (fi)
NL (1) NL970009I2 (fi)
NO (2) NO178139C (fi)
NZ (1) NZ228781A (fi)
PT (1) PT91523B (fi)
ZA (1) ZA892885B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0593624T3 (da) * 1991-07-05 1997-05-20 Nycomed Imaging As Forbedringer af eller i relation til kontrastmidler
MX9205298A (es) 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
JP3231768B2 (ja) * 1991-09-17 2001-11-26 ソーナス ファーマシューティカルス，インコーポレイテッド 気体状超音波造影剤及び超音波造影剤として使用する気体の選定方法
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
NZ262237A (en) 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
EP0699445A3 (en) * 1994-08-04 1996-04-17 Gakko Houjin Toin Gakuen Process for the preparation of an ultrasonic microbubble contrast agent with a surfactant
DE19602930A1 (de) * 1996-01-18 1997-07-24 Schering Ag Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
JP2002527410A (ja) 1998-10-12 2002-08-27 マリンクロッド・インコーポレイテッド 新規超音波造影剤
DE19950311A1 (de) * 1999-10-13 2001-04-19 Schering Ag Die Verwendung von Trockenstopfen zur Erhöhung der Lagerstabilität von Ultraschallkontrastmitteln
DE19952738A1 (de) * 1999-10-27 2001-05-23 Schering Ag Verbesserte Suspensionen von Ultraschallkontrastmitteln
US7109167B2 (en) 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US6962071B2 (en) 2001-04-06 2005-11-08 Bracco Research S.A. Method for improved measurement of local physical parameters in a fluid-filled cavity
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2003074005A2 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
CA2517939C (en) 2003-03-03 2015-11-24 Dyax Corp. Peptides that specifically bind hgf receptor (cmet) and uses thereof
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
KR101001547B1 (ko) 2004-01-28 2010-12-17 삼성에스디아이 주식회사 섬유상 태양 전지 및 이의 제조 방법
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5196896B2 (ja) * 2007-07-13 2013-05-15 花王株式会社 微細気泡前駆体の製造方法
WO2021141595A1 (en) * 2020-01-10 2021-07-15 Advanced Microbubbles Laboratories Llc Preparation and preservation of collagen microbubbles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640271A (en) 1969-06-30 1972-02-08 Ibm Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
CA1170569A (en) 1980-11-17 1984-07-10 Julia S. Rasor Microbubble precursors and methods for their production and use
DE3141641A1 (de) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
JPS5920532A (ja) * 1982-07-23 1984-02-02 Nippon Denso Co Ltd 車載内燃機関の燃料調量制御方法
DE3313946A1 (de) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3313947A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3637926C1 (de) * 1986-11-05 1987-11-26 Schering Ag Ultraschall-Manometrieverfahren in einer Fluessigkeit mittels Mikroblaeschen

Also Published As

Publication number Publication date
NO1998014I1 (no) 1998-05-05
PT91523A (pt) 1990-04-30
NL970009I1 (nl) 1997-05-01
EP0365467A2 (de) 1990-04-25
AU627456B2 (en) 1992-08-27
FI890749A0 (fi) 1989-02-16
FI100170B (fi) 1997-10-15
NO178139C (no) 1996-01-31
ZA892885B (en) 1990-12-28
JPH02145528A (ja) 1990-06-05
EP0365467B1 (de) 1993-08-18
JPH0737394B2 (ja) 1995-04-26
AU3390089A (en) 1990-04-12
IL90028A0 (en) 1989-12-15
DK99789A (da) 1990-04-08
DK99789D0 (da) 1989-03-01
NO890609D0 (no) 1989-02-13
ES2059814T3 (es) 1994-11-16
NZ228781A (en) 1992-03-26
KR970001433B1 (ko) 1997-02-06
FI890749A (fi) 1990-04-08
PT91523B (pt) 1995-05-31
DE58905318D1 (de) 1993-09-23
CN1027575C (zh) 1995-02-08
IE65243B1 (en) 1995-10-04
NO890609L (no) 1990-04-09
KR900005939A (ko) 1990-05-07
LU90004I2 (fr) 1997-03-04
ATE93145T1 (de) 1993-09-15
EP0365467A3 (en) 1990-06-06
NO178139B (no) 1995-10-23
IE891149L (en) 1990-04-07
CA1338507C (en) 1996-08-06
CN1044225A (zh) 1990-08-01
DE3834705A1 (de) 1990-04-12
NL970009I2 (nl) 1997-08-01

Similar Documents

Publication Publication Date Title
IL90028A0 (en) Solid microparticles containing fatty acids,contrast medium containing the same and kits for the preparation thereof
Walsh et al. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia
MY134715A (en) Contrast agents for ultrasound imaging
ATE96661T1 (de) Weichgelatinekapseln und verfahren zu ihrer herstellung.
ATE45287T1 (de) Enterales kontrastmittel fuer die kernspintomographie und dessen herstellung.
NZ207853A (en) Ultrasound contrast agent containing microparticles and gas micro-bubbles
EP1394256A3 (en) HCV genomic sequences for diagnostics and therapeutics
FR2385403B1 (fi)
ATE80801T1 (de) Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.
Kobayashi et al. Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
Chaudhuri et al. Uptake of 87mSr by liver metastasis from carcinoma of colon
Roth et al. Lipemia-Induced Acceleration of Intravascular Clotting.
Skjennald et al. Comparison of iohexol and meglumine-Na-Ca metrizoate in visceral angiography
Weinstein et al. The requirement of free fatty acids for the fatty liver of CCl4 intoxication
KR20020052072A (ko) 초음파 조영제 및 그의 제조방법
ENEMAS be taught is diminishing, partly as increasing
Dhopeshwarkar et al. Blood-Brain Barrier System
ALLARD et al. Discordant uptake of technetium-99m DISIDA and technetium-99m sulfur colloid in an amebic abscess
Nakatsuka et al. Radioactive benzodiazepine derivatives
Perper INSULIN TOLERANCE TEST IN DEPRESSED AND NORMAL SUBJECTS: DIFFERENTIAL EFFECTS ON TRYPTOPHAN AND GLUCOSE PLASMA LEVELS.
RU92004556A (ru) Контрастное вещество для ультразвуковой диагностики и способ его получения
RU95117020A (ru) Способ диагностики межпредсердного дефекта

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force